ALKERMES | ALKS - Los Ingresos Por Intereses





Los Ingresos Por Intereses Cambio Fecha
AbbVie USD 59M 13M 2025-12
Acadia Pharmaceuticals USD 8.33M 86K 2025-12
ALKERMES USD 8.54M 3.59M 2026-03
Biogen USD 37.9M 700K 2026-03
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Eli Lilly USD 65M 25M 2025-09
Gilead Sciences USD 95M 7M 2025-12
Heron Therapeutics USD 433K 277K 2021-12
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
J&J USD 2.14 237M 2026-03
Merck USD 69M 27M 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Otsuka Holdings JPY 10.49B 396M 2024-06
Pfizer USD 115M 51M 2026-03
Regeneron Pharmaceuticals USD 193.3M 18.2M 2025-12
Vertex Pharmaceuticals USD 114.8M 7.1M 2026-03